Skip to main content
logo
Ionis Pharmaceuticals, Inc. (LON:0JDI)
London flag London · Delayed Price · Currency is GBP · Price in USD
41.81
-0.73 (-1.72%)
At close: Jul 11, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Commercial Licensing and Other Royalty
22.60M
Log In
Log In
Log In
Log In
Upgrade
Commercial Licensing and Other Royalty Growth
-31.16%
Log In
Log In
Log In
Log In
Upgrade
Total R&D
-
Log In
Log In
Log In
Log In
Upgrade
Total R&D Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
38.00K
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-99.98%
Log In
Log In
Log In
Log In
Upgrade
SPINRAZA Royalties
216.10M
Log In
Log In
Log In
Log In
Upgrade
SPINRAZA Royalties Growth
-1.36%
Log In
Log In
Log In
Log In
Upgrade
TEGSEDI and WAYLIVRA
34.20M
Log In
Log In
Log In
Log In
Upgrade
TEGSEDI and WAYLIVRA Growth
-12.43%
Log In
Log In
Log In
Log In
Upgrade
Amortization from Upfront Payments
131.40M
Log In
Log In
Log In
Log In
Upgrade
Amortization from Upfront Payments Growth
-
Log In
Log In
Log In
Log In
Upgrade
Milestone Payments
106.40M
Log In
Log In
Log In
Log In
Upgrade
Milestone Payments Growth
-
Log In
Log In
Log In
Log In
Upgrade
R&D License Fees
71.30M
Log In
Log In
Log In
Log In
Upgrade
R&D License Fees Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other R&D Services
23.50M
Log In
Log In
Log In
Log In
Upgrade
Other R&D Services Growth
-
Log In
Log In
Log In
Log In
Upgrade
Eplontersen Joint Development
79.40M
Log In
Log In
Log In
Log In
Upgrade
Eplontersen Joint Development Growth
-29.66%
Log In
Log In
Log In
Log In
Upgrade
WAINUA Royalties
20.20M
Log In
Log In
Log In
Log In
Upgrade